Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Voyager Therapeutics (VYGR) Receivables - Other (2019 - 2025)

Voyager Therapeutics' Receivables - Other history spans 7 years, with the latest figure at $151000.0 for Q4 2025.

  • For Q4 2025, Receivables - Other fell 77.66% year-over-year to $151000.0; the TTM value through Dec 2025 reached $151000.0, down 77.66%, while the annual FY2025 figure was $151000.0, 77.66% down from the prior year.
  • Receivables - Other for Q4 2025 was $151000.0 at Voyager Therapeutics, down from $851000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $3.7 million in Q3 2024 and bottomed at $151000.0 in Q2 2022.
  • The 5-year median for Receivables - Other is $791500.0 (2021), against an average of $1.3 million.
  • The largest annual shift saw Receivables - Other tumbled 98.77% in 2021 before it skyrocketed 2118.54% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $732000.0 in 2021, then tumbled by 64.89% to $257000.0 in 2022, then surged by 1200.0% to $3.3 million in 2023, then crashed by 79.77% to $676000.0 in 2024, then crashed by 77.66% to $151000.0 in 2025.
  • Per Business Quant, the three most recent readings for VYGR's Receivables - Other are $151000.0 (Q4 2025), $851000.0 (Q3 2025), and $851000.0 (Q2 2025).